Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

Copenhagen Doctors Aps Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Bankruptcy risk for industry   1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 0.7% 0.7%   Bankruptcy risk   5.5% 5.1% 10.1% 3.8% 2.6% 1.9% 16.2% 16.2%   Credit score (0-100)   42 44 24 49 60 68 11 11   Credit rating   BBB BBB BB BBB BBB A BB BB   Credit limit (kDKK)   0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   2,040 2,108 1,550 2,263 2,530 2,811 0.0 0.0   EBITDA   498 328 -151 417 466 540 0.0 0.0   EBIT   335 247 -201 353 357 368 0.0 0.0   Pre-tax profit (PTP)   318.3 242.9 -202.8 339.7 350.5 347.7 0.0 0.0   Net earnings   245.9 185.6 -161.6 263.3 260.4 271.0 0.0 0.0   Pre-tax profit without non-rec. items   318 243 -203 340 351 348 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Tangible assets total   189 40.5 194 405 596 679 0.0 0.0   Shareholders equity total   37.5 223 38.5 302 462 615 293 293   Interest-bearing liabilities   172 0.0 0.0 38.8 54.8 54.2 0.0 0.0   Balance sheet total (assets)   537 421 353 860 1,028 1,323 293 293   Net Debt   23.3 -195 -24.6 -165 -230 -435 -293 -293     See the entire balance sheet 1000.0 Volume  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   2,040 2,108 1,550 2,263 2,530 2,811 0.0 0.0   Gross profit growth   12.6% 3.3% -26.5% 46.0% 11.8% 11.1% -100.0% 0.0%   Employees   1 2 2 3 3 3 0 0   Employee growth %   0.0% 100.0% 0.0% 50.0% 0.0% 0.0% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   537 421 353 860 1,028 1,323 293 293   Balance sheet change%   -24.0% -21.6% -16.1% 143.4% 19.6% 28.7% -77.8% 0.0%   Added value   498.3 327.6 -151.1 416.8 421.4 540.4 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   -326 -230 103 147 83 -89 -679 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   2.0 3.0 -1.0 1.0 2.0 3.0 0.0 0.0   1000.0 Profitability  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   16.4% 11.7% -13.0% 15.6% 14.1% 13.1% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   46.2% 51.5% -52.0% 58.2% 37.9% 31.3% 0.0% 0.0%   ROI %   156.3% 114.1% -154.1% 186.2% 67.3% 47.4% 0.0% 0.0%   ROE %   66.0% 142.4% -123.6% 154.8% 68.2% 50.3% 0.0% 0.0%   1000.0 Solidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Equity ratio %   7.0% 53.0% 10.9% 35.1% 45.0% 46.5% 100.0% 100.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   4.7% -59.5% 16.3% -39.6% -49.4% -80.5% 0.0% 0.0%   Gearing %   457.1% 0.0% 0.0% 12.9% 11.9% 8.8% 0.0% 0.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   8.7% 4.3% 0.0% 67.8% 14.6% 38.2% 0.0% 0.0%   1000.0 Liquidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Quick Ratio   0.8 1.9 0.5 0.8 1.2 1.2 0.0 0.0   Current Ratio   0.8 1.9 0.5 0.8 1.2 1.2 0.0 0.0   Cash and cash equivalent   148.2 194.8 24.6 203.9 284.8 489.2 0.0 0.0   1000.0 Capital use efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   -102.9 182.6 -157.5 -105.1 67.6 97.0 0.0 0.0   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   498 164 -76 139 140 180 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   498 164 -76 139 155 180 0 0   EBIT / employee   335 123 -101 118 119 123 0 0   Net earnings / employee   246 93 -81 88 87 90 0 0